Imatinib vs Metformin
Imatinib vs Metformin: Overview
This comparison examines the pharmacological differences between Imatinib and Metformin.
Mechanism of Action
Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.
Metformin: Activates AMP-activated protein kinase, decreasing hepatic glucose production.
Pharmacokinetics
Half-life: Imatinib — 18 hours; Metformin — 4-9 hours.
Chemical Properties
Molecular Formula: Imatinib — C29H31N7O; Metformin — C4H11N5.
Molecular Weight: Imatinib — 493.6030 g/mol; Metformin — 129.1640 g/mol.
Type: Imatinib — Small molecule; Metformin — Small molecule.